Authors' reply to commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Authors:
Publisher website
Google Scholar
Abstract
We wish to emphasize three issues concerning our study: its quality, its reporting and its transparency. We would encourage those interested in objectively assessing its quality to review not only the original 13-page publication, but also the 54 pages of supplementary material freely available on the BMJ website [http://www.bmj.com/content/357/bmj.j1909], to form their own conclusions.1